Grünenthal is a global leader in pain management. We are driven to seek effective, life-changing medicines and solutions for patients with severe diseases and high unmet medical needs.

... Company

A world free of pain. This is our shared vision. To bring it to life, we execute our strategy and work on our company’s culture – everyday, everywhere, every one of us.

... We are Grünenthal

Grünenthal’s product portfolio, brands, ingredients and indication range.

... Products

A mix of strong entrepreneurial spirit, close collaboration, and outstanding performance define our approach to leadership alongside a commitment to diversity and inclusivity.

... Leadership

The Supervisory Board advises and controls the Corporate Executive Board and is elected by the shareholders’ summit.

... Supervisory Board

Grünenthal is a global leader in pain management. Our purpose is to change lives for the better – and innovation is our passion. We are driven to seek effective, life-changing medicines and solutions for patients with severe diseases and high unmet medical needs.

... Partnering

In view of our vision of a World Free of Pain, Grünenthal strives to provide effective medication to patients worldwide. Therefore, we continuously grow and expand our market presence and product portfolio, and we collaborate with commercial partners and multiple stakeholders from the pain management field and beyond.

... Global presence & sites

Although firmly rooted in Germany, today we are very much a growing global Business.

... History

Explore our media section and access a range of materials relating to our company.

... Media

Grünenthal is a global leader in pain management and related diseases. Our purpose is to change lives for the better – and innovation is our passion. We are focusing all of our activities and efforts on moving towards our vision of a world free of pain. Explore our recent stories to see what drives us.

... Our Stories

In this section you will find both current and archived press releases published from 2019 onwards by Grünenthal GmbH, Germany.

... Press releases

... Statements

Journalists are invited to use our corporate publications for their reporting. The list contains business related publication like the company presentation or the code of conduct. .

... Corporate publications

Journalists are invited to use images from our library to illustrate their reporting. The library contains company and R&D related pictures.

... Image resources

The library contains a set of company footage. Journalists are invited to use the video material to illustrate their reporting.

... Video resources

Media - Our stories

Explore our recent stories to see what drives us

31 July 2025

Five future-facing facilities manufacturing medicines for patients worldwide

Grünenthal manufacturing facility

177 million packs of Grünenthal medicines reached patients in 2024. That’s a huge number of tablets and sprays that started their journey in one of five advanced production facilities worldwide, which in turn, made it possible for these medicines to reach the right people at the right time with the right quality.

They glide past rough-faced mountains in Switzerland. They zoom along beneath clear blue skies in Chile. Medicines from Grünenthal travel the globe to make life better for pain patients and their families, and they all begin that journey at one of our five world-class production sites.

Get to know our world-class manufacturing sites

Aachen Packaging Site, Germany

Aachen Packaging Site, Germany

Aachen API Site, Germany

Aachen API Site, Germany

Mitlödi API Site, Switzerland

Mitlödi API Site, Switzerland

Origgio Site, Italy

Origgio Site, Italy

Quito Site, Ecuador

Quito Site, Ecuador

Santiago Site, Chile

Santiago Site, Chile

Expert teams at these five manufacturing facilities make products for Grünenthal, as well as for key industry partners who rely on us for their manufacturing business to ensure patients in need receive the treatments they rely on. Our sites operate with a sharp focus on quality, safety and sustainability at all times. In 2024, the dedicated people at our state-of-the-art sites produced 177 million packs of medicines for patients.

Read more about Grünenthal’s production and manufacturing sites in the Grünenthal Report and discover how our Contract Manufacturing Business supports partners around the world here.

Contract Manufacturing, Strategy, Responsibility